Hereditary benign chorea
Clinical and genetic features of a distinct disease
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To describe a second family with benign hereditary chorea (BCH, OMIM 118700) and suggestive linkage to chromosome 14q. BCH is an autosomal dominant disorder of early onset that differs from Huntington disease in being nondementing and nonprogressive without other neurologic signs. There has been controversy regarding the existence of BCH as a discrete disorder.
Background: A single kindred was recently reported with linkage of BCH to a 20.6-KcM region on chromosome 14q.
Methods: In a four-generation family with BCH, linkage was evaluated to markers in a 23-KcM region between D14S49 and D14S66 that contains the putative BCH locus.
Results: A multipoint nonparametric lod score of 3.01 is consistent with linkage of disease in this family to the 14q BCH locus. A recombination event in one affected individual enabled the critical region to be narrowed to 6.93 KcM flanked by D14S1068 and D14S1064. This region contains two candidate genes: glial maturation factor beta and guanosine triphosphate cyclohydrolase 1 (GCH1). Survival motor neuron (SMN) interacting protein-1 is eliminated as a candidate gene because it lies outside the critical region. No sequence alteration was identified in the coding region of GCH1 in an affected individual.
Conclusion: These data provide further evidence that BCH is a distinct entity, narrow the location of BCH to a 6.93-KcM region on chromosome 14q, and exclude SMN interacting protein-1 as a candidate gene.
Chorea is a manifestation of a number of diseases, both acquired and inherited. Huntington disease (HD), the most common autosomal dominant disorder associated with chorea, usually manifests in the fourth to fifth decades of life, is associated with behavioral and personality changes, and is progressive. Benign hereditary chorea (BCH), or essential chorea, is another disorder characterized by choreiform movements, distinct in several ways from HD. In contrast to HD, in BCH the onset of choreiform movements is in early childhood; severity of symptoms peaks in the second decade and thereafter does not progress.1 Life expectancy is normal and there have been reports of disease improving with age.2
Since the first reports of this disease in the mid-1960s,3,4⇓ a total of 42 families have been reported and reviewed.5-7⇓⇓ Although BCH appears to be transmitted as an autosomal dominant disorder, there has been controversy as to whether non-HD familial chorea is a distinct disease or represents a heterogeneous group of disorders.7,8⇓ In one study of 12 families previously presumed to have BCH, further detailed evaluation allowed an alternative diagnosis to be made in at least 10, and “atypical features” were noted in an additional 31 families reported in the literature.7 Among the subsequent diagnoses were HD, ataxia telangiectasia, hereditary essential myoclonus, and hereditary forms of dystonia. Recently, however, linkage of BCH to a 20.6-KcM region on chromosome 14q was reported in a single large Dutch kindred.1 To evaluate whether the gene on 14q is responsible for disease in other BCH families, we performed a linkage analysis in a four-generation American family of English ancestry.
Methods.
Family.
The family (figure) was ascertained and clinically evaluated in the Neurogenetics Clinics at the University of Washington Medical Center and the Veterans Affairs Puget Sound Health Care System. Under protocols approved by the Institutional Review Board of the University of Washington, subjects were examined and blood samples were obtained from five affected members, one unaffected member, and two spouses from three generations of this family.
Figure. Pedigree of the family with benign hereditary chorea (BCH). Gray-filled symbols represent affected status and open symbols represent unaffected status. A slash line indicates deceased status. Some persons in generations I and II are indicated as affected based on family recollection and description. The 14 markers included in the genotype analysis and their map locations are shown in the inset at the lower left; D14S1064 was not genotyped. On this map, previously specified flanking markers1 are indicated by thin arrows and the new proximal border of the critical region is shown by a thick arrow. Haplotypes are shown below symbols for subjects from whom DNA was obtained. Brackets indicate inferred genotypes. Genotypes are shown between the chromosome pair for markers where the phase is not known. On the pedigree, the thin arrow indicates a microsatellite mutation. BCH appears to be segregating with the black chromosomal segment. The recombination event refining the proximal border of the critical region is indicated by the thick arrow. Because the markers were not fully informative, the breakpoint cannot be more specifically defined.
Genotype analysis.
Genomic DNA was extracted from leukocytes or Epstein–Barr virus–transformed B-lymphocyte lines. Primers for markers on the long arm of chromosome 14 were obtained from Research Genetics (Huntsville, AL). One primer of each pair was end-labeled with [γ32]P by a T4 kinase reaction. Markers were PCR amplified in an MJ Research PTC-100 programmable thermal controller as previously described.9 Genomic DNA (80 ng) was PCR amplified in 10-μL volumes containing 200-μM deoxyribonucleoside triphosphates (dNTPs), 0.4-U Taq polymerase (Applied Biosystems, Foster City, CA), and final concentrations of 2.5 of mM MgCl2 and 0.2 μM each of the forward and reverse 32P-labeled primers under conditions suggested by the manufacturer. Alleles were determined from data obtained on 6% polyacrylamide gel electrophoresis and visualization of 32P-labeled amplimers. Haplotypes were constructed to minimize the recombination events that would be necessary for the observed genotypes.
Sequence analysis of the GCH1 gene.
Two primer sets were devised to amplify exon 1: GCH1.1aF 5′-GGAG-TTTAGCCGCAGACCT-3′ and GCH1.1aR 5′-GGTAGCC-CTTGGTGAAGAACT-3′; and GCH1.1bF 5′-TAACGAGC-TGAACCTCCCTAAC-3′ and GCH1.1bR 5′-AGTGAGGCAACTCCGGAAACT-3′. Sequencing of exons 2 through 5 of the guanosine triphosphate (GTP) cyclohydrolase 1 gene was done using PCR primers previously described.10,11⇓ Exon 6 was amplified using the primer pair GCH1.6F 5′-ACCAAACCAGCAGCTGTCTACTCC-3′ and GCH1.6R 5′-CAAACAAGACCGGACAGACA-3′. Herculase polymerase (Stratagene, La Jolla, CA) was used to amplify the GCH1.1aF/GCH1.1aR pair. All other amplifications were done with Promega Taq polymerase (Promega, Madison, WI). Amplified DNA was purified using the QIAquick PCR Purification Kit (QIAGEN, Valencia, CA) and sequencing was done using an ABI Prism 377 DNA sequencer (Applied Biosystems, Foster City, CA).
Linkage analysis.
Power analysis was performed with the SLINK and MLINK subprograms of the LINKAGE package version 5.0 (available at: http://linkage.rockefeller. edu/software/linkage).12 Two-point linkage analyses were performed with FASTLINK (version 3.0P) for DOS (available at: http://fastlink.nih.gov/pub/fastlink).13 Autosomal dominant inheritance with a disease allele frequency of 0.0001 and a penetrance of 0.90 was assumed for BCH. Multipoint linkage analysis was performed using GENEHUNTER (Falling Rain Genomics, Palo Alto, CA).14 Allele sizes and frequencies and order of the marker loci were obtained from the Genome Data Base. Previously described sex-averaged map distances15 are available from the Marshfield Web site.16 When possible, allele sizes on the autoradiographs were standardized by comparison with DNAs from Centre D’Etude du Polymorphisme Humain families 1331 and 1347.17
Results.
This family was originally reported as having essential nonprogressive chorea with an autosomal dominant inheritance pattern.18 The syndrome manifests as early childhood onset of sudden choreiform movements of small amplitude, generally involving the distal parts of the upper extremities, but also involving the feet, shoulders, head, and face. The movements are worsened by anxiety but not by voluntary movements, exercise, startle, caffeine, or alcohol. The adventitious movements increase in severity until early adolescence, when progression ceases, and the symptoms may improve in adulthood. Although the condition is not associated with dementia or a decrease in lifespan, it can be socially disabling. Some members of the family have educational and behavioral difficulties.
The pedigree demonstrates an autosomal dominant pattern, with evidence of male-to-male transmission, no evidence for decreased penetrance, but variable expressivity in terms of severity. The ages at onset range from 2 to 5 years, although one subject was unaware of her status until examined at age 21 (IV-3). There is no evidence of genetic anticipation.
Clinical evaluations of three affected members of this family are described in detail; the others are summarized in the table. Individual IV-2, a man with normal intellect, had onset in early childhood of choreic movements. Between ages 1 and 2 years he was noted to have jerky movements of the hands. When examined at age 6 years he had sudden, jerky movements of small amplitude involving the distal parts of the upper limbs. Similar movements were occasionally noted in the shoulder, feet, head, and face. Cranial nerve testing results were normal. He had mild difficulty hopping on one foot and was unable to skip. The rest of his coordination, gait, muscle strength, muscle tone, and sensation was normal. Deep tendon reflexes were hyperactive, but symmetric with flexor plantar responses. Wechsler Intelligence Scale for Children showed a verbal IQ of 106, performance IQ of 90, and full-scale IQ of 98. Over the intervening years he experienced many social problems associated with his movements. He left school after the ninth grade, had trouble maintaining employment, was turned down by the Navy, and has been inaccurately accused of being intoxicated. He has avoided drugs and medications. On examination at age 31, he had a normal mental status. He had brief, irregular movements of his arms, legs, trunk, and more frequently of his head. These were more evident when he was distracted and on turning or moving his head or body. Cranial nerves, muscle strength, muscle tone, and sensation were normal. His deep tendon reflexes were normal and symmetric with flexor plantar responses. His gait was steady and Romberg sign was negative. Blood ceruloplasmin level, EEG, and HD DNA test results were all normal.
Phenotypic features of benign hereditary chorea in the family
Individual II-3, a woman with normal intellect, had onset of the disease in early childhood with improvement of her movements in adulthood. As an adult she noted occasional, sudden extension spasms of her neck lasting seconds. Examination at age 47 years showed moderate, choreiform movements of her distal upper and lower extremities and head. At age 71 years, she was living in a nursing home and had a history of the onset of moderate memory loss beginning in her mid 60s. Examination showed infrequent, brief jerks of her upper limbs and brief orolingual quivering. The movements were much less noticeable than at age 47. Her cranial nerves were normal. She had normal to brisk, symmetric, deep tendon reflexes and flexor plantar responses. She uses levothyroxine for hypothyroidism and hydrochlorothiazide for hypertension. She has used chlordiazepam, phenobarbital, and chlorazepate without improvement of her movements.
This woman’s mother (I-2) had medical records indicating the onset of adventitious movements before age 6 years and a diagnosis of St. Vitus dance (Sydenham chorea) at age 12 years. As an adult she was described as having grimacing, twisting, turning movements called choreiform. At age 63 years she had a pneumoencephalogram showing normal caudate shadows (reviewed by us) and was thought not to have HD. EEG and CSF examination findings were normal. She died at age 67 years of lung cancer prior to the current study, but her medical records indicate that she had the most severe movement disorder in this family.
Individual III-5, the daughter of II-3, had onset of adventitious movements at age 5 years. The movements did not increase in frequency or severity except transiently during pregnancy. Examination at age 18 years showed frequent mild choreiform movement of her hands, feet, arms, and face. The movements were increased by anxiety. The rest of the neurologic examination findings were normal. Examination at age 42 years showed a normal mental status. She had mild to moderate chorea of arms, legs, face, and trunk. Cranial nerve examination findings were normal. Strength, muscle tone, and sensation were normal. She had a mild fine tremor of her outstretched hands. Coordination and gait were normal. She had normal to brisk tendon reflexes with flexor plantar responses. Historically, phenobarbital was not beneficial, but she reported that 10 mg/day of diazepam caused mild improvement. She was not using medication at the time of examination. Her two daughters were found to be affected on examination at ages 21 and 14 years. Individual IV-4 was examined by three of the authors (M.F., H.L., and T.B.) and had clear adventitious movements that had been noted by her mother for many years, although a precise age at onset could not be determined.
Genetic analysis.
The family was genotyped for 14 markers in a 23-KcM region on chromosome 14q between markers D14S49 and D14S66 that contains the putative BCH locus. Although power analysis suggested the available samples could provide a maximum two-point lod score of 1.46, none of the markers was fully informative and the two-point analysis was indeterminate. However, the maximum multipoint lod score of 1.39 and nonparametric lod score of 3.01 at D14S66 are consistent with linkage to the BCH region. The distal border of the critical region remains at D14S1064.1 A recombination event in individual IV-4, identified by haplotype analysis, enabled the proximal border to be respecified at D14S1068 and narrowed the critical region to 6.93 KcM (figure).
Mutation analysis of guanosine triphosphate cyclohydrolase 1.
The six exons of GTP cyclohydrolase were amplified and sequenced directly from an affected subject (II-3), an unaffected subject (III-7), and a normal control (II-2). One C to G substitution was detected at position −53 in intron 1 in the unrelated subject, but no sequence alterations were detected in the other subjects. Analysis of exon 1 extended 32 base pairs into the 5′ untranslated region and included nucleotide −22 that was mutated in one subject with dopa-responsive dystonia.19
Discussion.
We have described a second family with BCH localizing to 14q, refined the proximal border of the critical region, and narrowed the region to 6.93 KcM. Two of three previously suggested candidate genes, glial maturational factor beta and GCH1, lie within this region, but survival motor neuron (SMN) interacting protein is excluded by its location outside the narrowed region.1
The GCH1 gene is of special interest because it is responsible for dopa-responsive dystonia. Both BCH and dopa-responsive dystonia are movement disorders of early onset. Individuals I-2 and II-3 had brief sudden neck spasms that could represent dystonia. However, no mutations were found by direct sequencing of the coding region and the contiguous 32 nucleotides of the 5′ untranslated region. It remains possible that a mutation outside this region is responsible for disease in this family. It would be reasonable to perform sequence analysis in additional families whose disease localizes to chromosome 14. It is also interesting that the locus for a syndrome of basal ganglia calcification20 characterized by chorea, dystonia, parkinsonism, and tremors was recently mapped to this same genomic region; GCH1 lies outside the minimal region for familial calcification of the basal ganglia. Glial maturational factor beta remains a candidate gene for BCH.
The phenotype of BCH is most commonly confused with two other causes of chorea, namely HD and Sydenham chorea. BCH differs from HD in that it is nonprogressive, does not involve deteriorating cognitive or behavioral changes, does not have caudate atrophy on neuroimaging, and has a normal-sized CAG repeat in the HD gene. Although subjects in our family and in the previously described family1 have been thought to have Sydenham’s chorea, BCH is present for years or even decades, is not associated with rheumatic fever, and has a family history. Several of the children in our family have had difficulties in school, but it is unclear whether this is a direct consequence of the CNS disease or related to problems with social interaction. Several were unable to finish school and experienced serious social isolation. A single person in this family (II-3) has had mild late-onset dementia. This may be coincidental because no other person in this family or the previously described family1 has developed dementia.
Benign familial chorea is a heterogeneous syndrome that may have a variety of causes.7 Many families with this initial diagnosis prove to have other disorders when more thoroughly evaluated or followed up for long periods. This has even been the case with one of our other families initially thought to have BCH but now shown to have familial dyskinesia with myokymia.21 Nevertheless, previous findings1 combined with our current study demonstrate that there is a distinct genetic entity of early-onset, nonprogressive, uncomplicated chorea with a locus on 14q.
Acknowledgments
Supported by the Department of Veterans Affairs (T.B., H.L., W.R., J.W.) and NIH 1 T32 AG00258–01A1 (M.F.).
Acknowledgment
The authors thank the BCH family for their cooperation.
- Received January 11, 2001.
- Accepted March 10, 2001.
References
- ↵
- ↵
- ↵
Haerer AF, Currier RD, Jackson JF. Hereditary nonprogressive chorea of early onset. N Engl J Med . 1967; 276: 1220–1224.
- ↵
- ↵
Bruyn GW, Myrianthopoulos NC. Chronic juvenile hereditary chorea (benign hereditary chorea of early onset). In: Viken PJ, Bruyn GW, Klawans HL, eds. Handbook of clinical neurology. Extrapyramidal disorders, vol 5. Amsterdam: Elsevier Science, 1986: 335–348.
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
Lathrop GM, Lalouel JM, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA . 1984; 81: 3443–3446.
- ↵
- ↵
- ↵
- ↵
Marshfield Clinic Web site. Available at: http://research.marshfieldclinic.org/genetics/Map_markers/Maps/IndexMapFrames.html. Accessed October 6, 2000.
- ↵
- ↵
Bird TD, Carlson CB, Hall JG. Familial essential (“benign”) chorea. J Med Genet . 1976; 13: 357–362.
- ↵
Tassin J, Dürr A, Bonnet A-M, et al. Levodopa-responsive dystonia: GTP cyclohydrolase I or parkin mutations? Brain . 2000; 123: 1112–1121.
- ↵
- ↵
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Resident & Fellow Section
Clinical Reasoning: Importance of clinical phenomenology in the era of genetic testingMeera R. Basu, Alberto J. Espay, Emily G. Wakefield et al.Neurology, February 05, 2018 -
Articles
Hereditary Late-Onset Chorea Without Significant DementiaGenetic Evidence for Substantial Phenotypic Variation in Huntington's DiseaseJ. W. Britton, R. J. Uitti, J. E. Ahlskog et al.Neurology, March 01, 1995 -
Articles
SMN1 gene, but not SMN2, is a risk factor for sporadic ALSP. Corcia, W. Camu, J. -M. Halimi et al.Neurology, August 23, 2006 -
Review
The non–Huntington disease choreasFive new thingsRuth H. Walker et al.Neurology: Clinical Practice, March 16, 2016